CLEO to Fast Track Development of Ovarian Cancer Test
Filed with ASX · · 4 pages · English
Earlier from CLEO Diagnostics
- CLEO Receives A$845k Research and Development Tax Incentive
- CLEO Delivers Commercial Development Milestone
- Price Query Response
- CLEO Further Expands Ovarian Cancer Trial with Siles Health
- The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial
Later from CLEO Diagnostics
- Cleo Advances with Completion of Alpha Testing
- Corporate Presentation
- CLEO Strengthens FDA Submission - Access to US Biobank
- COV Commences Health Economic Study-Support US Market Entry
- Appendix 4E and 2025 Annual Report
Follow CLEO Diagnostics into a list and get an email when it puts out news.
Follow CLEO Diagnostics